[Trastuzumab emtansine in the systemic treatment of HER-2-positive breast cancer brain metastases]

Bull Cancer. 2016 May;103(5):507-10. doi: 10.1016/j.bulcan.2016.02.005. Epub 2016 Mar 15.
[Article in French]
No abstract available

Keywords: Anti-HER2 systemic treatment; Brain metastases; Breast cancer; Cancer du sein; Métastases cérébrales; Traitement systémique anti-HER2.

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Ado-Trastuzumab Emtansine
  • Adult
  • Aged
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Brain Neoplasms / diagnostic imaging
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / secondary*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology*
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Maytansine / analogs & derivatives*
  • Maytansine / therapeutic use
  • Middle Aged
  • Receptor, ErbB-2 / metabolism
  • Trastuzumab

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Maytansine
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Trastuzumab
  • Ado-Trastuzumab Emtansine